SGHT Q1 2022 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$15M+72.3% YoY

Gross Profit

$12M79.6% margin

Operating Income

-$22M-149.1% margin

Net Income

-$23M-156.3% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

+1.3%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$259M

Total Liabilities

$47M

Stockholders' Equity

$212M

Cash & Equivalents

$239M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$9M	+72.3%
Gross Profit	$12M	$6M	+87.1%
Operating Income	-$22M	-$12M	-90.4%
Net Income	-$23M	-$12M	-90.1%

Revenue Segments

Surgical Glaucoma

$14M93%

Dry Eye

$1M7%